Post by
Ingiboy on Aug 02, 2022 10:06am
Today's NR
"Independent Testing Performed by Innovacell Demonstrates the DermaPrecise™ Control Leads to Unparalleled Post-Injection Cell Survival and Viability Consistency"
This is great news for this device. It posibly makes Dermaprecise the most sophisticated injection device available for cell injections. This will get the attention of large pharma.
In the NR I was looking for the word "clinical" meaning human testing. It is not clear to me that it was a clinical test. I hope it was because that will bring the device very close to a submission for FDA Approval.
Comment by
cashworx46 on Aug 02, 2022 12:06pm
This post has been removed in accordance with Community Policy